New possibilities for the therapy of secondary progressive multiple sclerosis

Patients with multiple sclerosis (MS) are at high risk for transition to secondary progressive MS (SPMS). To date, there has not been a sufficiently effective therapy for SPMS. Siponimod is a selective sphingosine-1-phosphate types 1 and 5 receptor modulator that has been shown to be more effective...

Full description

Bibliographic Details
Main Authors: A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2019-12-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
Online Access:https://nnp.ima-press.net/nnp/article/view/1221